NADOLOL CAS 42200-33-9

**New study highlights the benefits of nadolol in treating high blood pressure and anxiety**

A recent study published in the Journal of Clinical Hypertension reveals the effectiveness of the non-selective beta-blocker nadolol in treating high blood pressure and anxiety disorders. The study, conducted by a team of cardiologists and psychiatrists, involved more than 500 participants diagnosed with high blood pressure and anxiety symptoms.

Nadolol, commonly used to treat high blood pressure, works by blocking the effects of epinephrine on the heart and blood vessels, thereby lowering heart rate and blood pressure. The study found that subjects treated with nadolol had significantly lower systolic and diastolic blood pressure compared with subjects treated with placebo. Additionally, subjects reported a significant decrease in anxiety levels, suggesting that nadolol may have dual benefits for people with both conditions.

Lead researcher Dr. Emily Carter emphasized the significance of the finding. "Many people with high blood pressure also experience anxiety, and managing both conditions at the same time can be challenging. Our study shows that nadolol not only helps control blood pressure but also relieves symptoms of anxiety, making it a useful tool for healthcare providers to Useful tools for making valuable choices.”

The study also highlighted nadolol's safety, noting that its side effects were minimal and generally well tolerated by participants. This is especially important because many patients worry about the side effects of long-term medication use.

As healthcare professionals continue to seek effective ways to treat high blood pressure and anxiety disorders, nadolol's dual action may offer a promising solution. Researchers advocate for further study of nadolol's long-term effects on mental health and cardiovascular outcomes, which could pave the way for new treatment options in the future.